Manchester-based Boston Therapeutics posts wider net loss for quarter
The Company had a net loss of $667,422, or ($0.04) per share, for the quarter ended March 31, 2013 compared with a net loss of $257,405 or ($0.02) for the same period in the prior year. The Company's cash balance at March 31, 2013 was $384,674.
LATEST NEW HAMPSHIRE ANGLE
Ruth Graham: Whatever your theology, your denomination, your interests, and your appetite for cursing, there’s a Christian podcast for you.
Joe McQuaid's Publisher's Notes: President's offspring always off limits? My grandfather would beg to differ